Get the Stockscreener App
137.70
0.51%
0.70
Irhythm Technologies Inc stock is traded at $137.70, with a volume of 493.05K.
It is up +0.51% in the last 24 hours and up +33.11% over the past month.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$137.00
Open:
$138.08
24h Volume:
493.05K
Relative Volume:
1.08
Market Cap:
$4.19B
Revenue:
$560.03M
Net Income/Loss:
$-150.66M
P/E Ratio:
-28.33
EPS:
-4.86
Net Cash Flow:
$-87.43M
1W Performance:
+5.02%
1M Performance:
+33.11%
6M Performance:
+59.23%
1Y Performance:
+37.87%
1-Day Range:
$136.89
$139.53
1-Week Range:
$128.76
$140.73
52-Week Range:
$55.92
$140.73
Irhythm Technologies Inc Stock (IRTC) Company Profile
Name
Irhythm Technologies Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
137.70 | 4.19B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Technologies Inc Stock (IRTC) Latest News
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iRhythm Technologies, Inc. (IRTC) - ACCESS Newswire
Investors who lost money on iRhythm Technologies, Inc. (IRTC) should contact Levi & Korsinsky about pending Class ActionIRTC - ACCESS Newswire
iRhythm (IRTC) Receives Price Target Boost from Truist Analyst | - GuruFocus
iRhythm (IRTC) Receives Price Target Boost from Truist Analyst | IRTC Stock News - GuruFocus
iRhythm Technologies (IRTC) Raises Revenue Guidance Amid Growth - GuruFocus
iRhythm Technologies (IRTC) Beats Estimates, Forecasts Robust Growth - GuruFocus
iRhythm Technologies First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q1 2025 Earnings Call Transcript - Insider Monkey
Wells Fargo Upgrades iRhythm Technologies (LSE:0A7L) - Nasdaq
iRhythm Technologies, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights – IRTC - ACCESS Newswire
Wells Fargo Upgrades iRhythm Technologies Stock, Raises Price Target To $130: Retail’s Thrilled - MSN
IRhythm Technologies Shares Jump After Q1 Revenue Beat - marketscreener.com
Wells Fargo Upgrades iRhythm Technologies Stock, Raises Price Target To $130: Retail’s Thrilled By Stocktwits - Investing.com India
Wells Fargo Upgrades iRhythm Technologies (BIT:1IRTC) - Nasdaq
Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts - Benzinga
IRTC: Canaccord Genuity Maintains Buy Rating but Lowers Price Target | IRTC Stock News - GuruFocus
Wells Fargo Upgrades iRhythm Technologies (IRTC) - Nasdaq
Baird Raises Price Target for iRhythm Technologies (IRTC) | IRTC Stock News - GuruFocus
This FTAI Aviation Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday - Benzinga
iRhythm stock gets a boost on Q1 results, continued momentum with Zio launch in Japan - MassDevice
IRTC Stock Boosted by Wells Fargo Upgrade and Price Target Raise | IRTC Stock News - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Baird Boosts iRhythm (IRTC) Price Target to $150, Maintains Outp - GuruFocus
Baird Boosts iRhythm (IRTC) Price Target to $150, Maintains Outperform Rating | IRTC Stock News - GuruFocus
IRTC: Needham Raises Price Target for iRhythm Technologies | IRT - GuruFocus
IRTC: Needham Raises Price Target for iRhythm Technologies | IRTC Stock News - GuruFocus
Deep Dive Into iRhythm Technologies Stock: Analyst Perspectives (5 Ratings) - Benzinga
IRTC: BTIG Ups Price Target Following Strong Sales Performance | - GuruFocus
Canaccord Adjusts Price Target for iRhythm (IRTC), Maintains Buy Rating | IRTC Stock News - GuruFocus
IRTC: BTIG Ups Price Target Following Strong Sales Performance | IRTC Stock News - GuruFocus
Wells Fargo lifts iRhythm stock rating, targets $130 By Investing.com - Investing.com India
Wells Fargo Upgrades iRhythm Technologies to Overweight, Price Target is $130 - marketscreener.com
Wells Fargo Boosts iRhythm (IRTC) with Upgraded Rating and Highe - GuruFocus
iRhythm Technologies Inc (IRTC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges - GuruFocus
Wells Fargo Boosts iRhythm (IRTC) with Upgraded Rating and Higher Target | IRTC Stock News - GuruFocus
iRhythm Technologies Inc (IRTC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... By GuruFocus - Investing.com Canada
iRhythm Technologies Reports Strong Q1 2025 Growth - TipRanks
IRhythm Technologies Q1 Adjusted Loss Narrows, Revenue Rises; 2025 Sales Guidance Raised - marketscreener.com
iRhythm Technologies Inc (IRTC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
iRhythm (IRTC) Expands ECG Monitoring with Japanese Launch | IRT - GuruFocus
iRhythm Technologies, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:IRTC) - Seeking Alpha
Earnings call transcript: iRhythm Technologies Q1 2025 sees stock rise after revenue beat - Investing.com
Earnings call transcript: iRhythm Technologies Q1 2025 sees stock rise after revenue beat By Investing.com - Investing.com South Africa
iRhythm Q1 2025 presentation: Revenue jumps 20%, guidance raised on market expansion - Investing.com India
IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
iRhythm (NASDAQ:IRTC) Surprises With Strong Q1, Full-Year Sales Guidance is Optimistic - Yahoo Finance
iRhythm Technologies beats Q1 estimates, raises 2025 outlook; shares rise - Investing.com Australia
iRhythm Technologies beats Q1 estimates, raises 2025 outlook; shares rise By Investing.com - Investing.com South Africa
iRhythm Technologies, Inc. SEC 10-Q Report - TradingView
IRHYTHM TECHNOLOGIES Earnings Results: $IRTC Reports Quarterly Earnings - Nasdaq
iRhythm Technologies Announces First Quarter 2025 Financial Results - The Manila Times
Irhythm Technologies Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):